Paul Workman Selected Research

Paul Workman Research Topics

Disease

173	Neoplasms (Cancer) 01/2022 - 01/2002
16	Melanoma (Melanoma, Malignant) 01/2018 - 10/2006
14	Carcinoma (Carcinomatosis) 11/2013 - 01/2004
13	Colonic Neoplasms (Colon Cancer) 01/2018 - 06/2002
12	Glioblastoma (Glioblastoma Multiforme) 10/2017 - 03/2009
9	Ovarian Neoplasms (Ovarian Cancer) 11/2018 - 07/2002
7	Breast Neoplasms (Breast Cancer) 01/2020 - 01/2002
6	Prostatic Neoplasms (Prostate Cancer) 12/2021 - 03/2011
6	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 10/2003
6	Carcinogenesis 12/2016 - 01/2004
6	Hypoxia (Hypoxemia) 06/2011 - 07/2002
4	Glioma (Gliomas) 09/2009 - 06/2007
4	Neoplasm Metastasis (Metastasis) 04/2008 - 01/2002
3	Neuroblastoma 11/2020 - 11/2011
3	Cholangiocarcinoma 01/2020 - 01/2017
2	Chordoma 01/2021 - 01/2019
2	Leukemia 01/2020 - 11/2004
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020 - 10/2012
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 06/2014
2	Circulating Neoplastic Cells 01/2019 - 09/2009
2	Fatigue 01/2019 - 10/2008
2	Disease Progression 10/2017 - 06/2009
2	Ovarian Epithelial Carcinoma 01/2015 - 03/2008
2	Multiple Myeloma 10/2013 - 01/2012

Drug/Important Bio-Agent (IBA)

60	Pharmaceutical PreparationsIBA 01/2021 - 01/2002
43	Proteins (Proteins, Gene)FDA Link 12/2021 - 01/2002
29	Heat-Shock Proteins (Heat-Shock Protein)IBA 11/2018 - 01/2002
26	Biomarkers (Surrogate Marker)IBA 01/2020 - 04/2005
25	Molecular Chaperones (Chaperone, Molecular)IBA 01/2020 - 01/2002
21	tanespimycin (17AAG)IBA 11/2018 - 01/2002
20	Phosphotransferases (Kinase)IBA 01/2019 - 10/2004
16	Biological ProductsIBA 01/2020 - 10/2003
9	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2020 - 01/2004
9	Phosphorylcholine (Phosphocholine)IBA 07/2017 - 11/2003
8	PI103IBA 01/2017 - 06/2007
8	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 08/2013 - 10/2006
7	Oncogene Proteins (Oncogene Protein)IBA 01/2020 - 01/2002
6	Transcription Factors (Transcription Factor)IBA 01/2021 - 01/2012
6	Adenosine Triphosphate (ATP)IBA 01/2020 - 04/2009
6	RoscovitineIBA 01/2018 - 01/2004
6	Protein Isoforms (Isoforms)IBA 05/2017 - 09/2008
6	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2014 - 01/2006
6	Adenosine Triphosphatases (ATPase)IBA 01/2012 - 06/2004
5	Temozolomide (Temodar)FDA LinkGeneric 11/2020 - 02/2009
5	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2019 - 04/2005
5	Lactic Acid (Lactate)FDA LinkGeneric 07/2017 - 07/2013
5	2- (1H- indazol- 4- yl)- 6- (4- methanesulfonylpiperazin- 1- ylmethyl)- 4- morpholin- 4- ylthieno(3,2- d)pyrimidineIBA 01/2016 - 09/2008
5	Phosphorus (Red Phosphorus)IBA 01/2014 - 11/2003
4	RNA (Ribonucleic Acid)IBA 12/2021 - 10/2003
4	LigandsIBA 12/2021 - 03/2007
4	Choline (Choline Chloride)IBA 01/2017 - 01/2006
4	Protons (Proton)IBA 01/2014 - 11/2003
4	DNA (Deoxyribonucleic Acid)IBA 01/2014 - 12/2007
4	Aurora KinasesIBA 10/2012 - 05/2004
4	EnzymesIBA 09/2012 - 05/2004
4	LAQ824IBA 02/2012 - 08/2006
4	Histone Deacetylase InhibitorsIBA 02/2012 - 08/2006
4	5- (2,4- dihydroxy- 5- isopropylphenyl)- 4- (4- morpholin- 4- ylmethylphenyl)isoxazole- 3- carboxylic acid ethylamideIBA 01/2012 - 01/2008
4	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2012 - 09/2008
4	Imatinib Mesylate (Gleevec)FDA Link 09/2009 - 12/2003
3	ErbB Receptors (EGF Receptor)IBA 12/2021 - 05/2009
3	MicroRNAs (MicroRNA)IBA 11/2021 - 01/2007
3	Drug CombinationsIBA 01/2019 - 05/2012
3	Amino Acids FDA Link 10/2017 - 04/2009
3	MTOR InhibitorsIBA 07/2017 - 01/2016
3	Messenger RNA (mRNA)IBA 07/2017 - 02/2006
3	ProteomeIBA 01/2016 - 12/2009
3	Protein Kinases (Protein Kinase)IBA 11/2015 - 09/2008
3	Histones (Histone)IBA 05/2013 - 05/2004
3	Choline KinaseIBA 05/2012 - 01/2006
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2012 - 07/2002
3	LipidsIBA 01/2012 - 06/2007
3	Complementary DNA (cDNA)IBA 03/2011 - 02/2004
3	Phospholipids (Phosphatides)FDA LinkGeneric 07/2010 - 11/2003
3	Cytotoxins (Cytolysins)IBA 06/2009 - 05/2005
3	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 03/2007 - 12/2005
3	geldanamycinIBA 03/2006 - 01/2002
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2021 - 10/2004
2	Irinotecan (Camptosar)FDA LinkGeneric 11/2021 - 10/2004
2	Fluorouracil (Carac)FDA LinkGeneric 11/2021 - 10/2003
2	Brachyury protein (Brachyury)IBA 01/2021 - 01/2019
2	CYC065IBA 11/2020 - 01/2020
2	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 07/2002
2	Androgen Receptors (Androgen Receptor)IBA 01/2019 - 01/2016
2	(2,4- dihydroxy- 5- isopropylphenyl)- (5- (4- methylpiperazin- 1- ylmethyl)- 1,3- dihydroisoindol- 2- yl)methanoneIBA 01/2019 - 01/2016
2	Carboplatin (JM8)FDA LinkGeneric 11/2018 - 10/2008
2	Antineoplastic Agents (Antineoplastics)IBA 01/2018 - 09/2011
2	Phosphatidylcholines (Phosphatidylcholine)IBA 10/2017 - 01/2016
2	VemurafenibIBA 12/2016 - 01/2013
2	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 04/2016 - 09/2008
2	Mediator ComplexIBA 02/2016 - 12/2015
2	Hormones (Hormone)IBA 01/2016 - 11/2015
2	N-Myc Proto-Oncogene ProteinIBA 01/2016 - 11/2011
2	Ribosomal Proteins (Ribosomal Protein)IBA 01/2015 - 05/2010
2	Small Interfering RNA (siRNA)IBA 05/2014 - 02/2009

Therapy/Procedure

47	Therapeutics 01/2022 - 01/2002
11	Drug Therapy (Chemotherapy) 11/2021 - 10/2004
4	Precision Medicine 01/2022 - 12/2006
4	Castration 12/2021 - 03/2011
3	Radiotherapy 07/2017 - 06/2011